Low expression of RASSF10 was detected in 70.83% (204/288) of HCC tumors and 31.94% (92/288) of non-cancerous tissue samples (P < 0.001; Figure 1C). The gene discussed is RASSF10; the disease is hepatocellular carcinoma.